ICS: the model of excellence in global healthcare logistics
Value beyond compliance
Quality assurance
-
The ICS quality department maintains associates at all sites
Our quality professionals have certifications from external organizations, such as the American Society for Quality (ASQ), and have oversight for processes such as:
- Document control
- Audits
- ISO certification
- Temperature monitoring
- Inventory movement
-
Standardized procedures across the distribution network
-
Pilgrim quality management software tools implemented to drive continuous improvement
Compliance
-
Stringent ISO 9001:2015 standards and inspections
-
Drug Enforcement Administration (DEA) licensed distributor/importer
-
Customs Trade Partnership Against Terrorism (C-TPAT) certification
-
U.S Food and Drug Administration (FDA) licensed distributor
-
Current Good Manufacturing Practice (cGMP) and Prescription Drug Modification Act (PDMA) compliant
-
Code of Federal Regulations (CFR) Part 11 compliant
-
State board of pharmacy licensed
-
NABP (National Association of Boards of Pharmacy)
-
System and Organization Controls (SOC) 1 Type II compliant
Continuous improvement
-
As part of the quality department, the continuous improvement leadership is black belt certified, supported by a team of green belt certified associates
-
The continuous improvement team utilizes six sigma methodology to drive efficiencies throughout operations and has oversight for the non-conformance (NC) process utilized by ICS
-
We apply LEAN principles to create value
-
We utilize six sigma methodology
-
Cross-functional, problem-solving kaizen events ensure we improve continuously
ISO 9001:2015
ICS was the first pharmaceutical 3PL provider to receive the ISO 9001:2015 certification recommended by DQS inc.
The new version of the ISO standard delivers three critical benefits to manufacturers:
- Greater emphasis on leadership engagement
- Increased prominence on risk-based thinking by addressing organizational risks and opportunities in a structured manner
- Addresses supply chain management more effectively
ICS has implemented a robust suspicious order monitoring process, fueled by IQVIA, an industry leader for EA suspicious monitoring.
- Protects against diversion of pharmaceutical controlled substances and listed chemicals
- Continuously monitors all controlled substance orders and immediately flags those deemed potentially suspicious
- Automates the order review and decision-making process
- Includes processes for updating/changing volume expectations for existing and new customers
NC process flow and ownership
